Featured Research

from universities, journals, and other organizations

New trigger for ovulation could make IVF safer

Date:
July 18, 2014
Source:
Imperial College London
Summary:
A new and potentially safer method to stimulate ovulation in women undergoing IVF treatment has been developed by researchers. Twelve babies have been born after their mothers were given an injection of the natural hormone kisspeptin to make their eggs mature. Doctors normally administer another hormone, hCG, for this purpose, but in some women, there is a risk that this can overstimulate the ovaries, with potentially life-threatening consequences.

Researchers have successfully used a new and potentially safer method to stimulate ovulation in women undergoing IVF treatment.

Twelve babies have been born after their mothers were given an injection of the natural hormone kisspeptin to make their eggs mature. Doctors normally administer another hormone, hCG, for this purpose, but in some women, there is a risk that this can overstimulate the ovaries, with potentially life-threatening consequences.

Scientists at Imperial College London and clinicians at Imperial College Healthcare NHS Trust tested the new method in 53 healthy volunteers at Hammersmith Hospital in London. The study, funded by the Medical Research Council, the National Institute for Health Research and the Wellcome Trust, is published in the Journal of Clinical Investigation.

One in six couples in the UK experiences infertility, and 48,147 women underwent IVF treatment in 2011.

Ovarian hyperstimulation syndrome (OHSS) affects around a third of IVF patients in a mild form, causing symptoms such as nausea and vomiting. Less than 10 per cent of patients experience moderate or severe OHSS, which can cause kidney failure.

Professor Waljit Dhillo, from the Department of Medicine at Imperial College London, who led the study, said: "OHSS is a major medical problem. It can be fatal in severe cases and it occurs in women undergoing IVF treatment who are otherwise very healthy. We really need more effective natural triggers for egg maturation during IVF treatment, and the results of this trial are very promising."

Kisspeptin is a naturally occurring hormone that stimulates the release of other reproductive hormones inside the body. Unlike hCG, which remains in the blood for a long time after an injection, kisspeptin is broken down more quickly, meaning the risk of overstimulation is lower.

The women in the study had a single injection of kisspeptin to induce ovulation. Mature eggs developed in 51 out of 53 participants. Forty-nine women had one or two fertilised embryos transferred to the uterus, and 12 became pregnant, which is a good outcome compared to standard conventional IVF therapy.

The researchers will now carry out a second study in women with polycystic ovary syndrome, who have the highest risk of OHSS.

"Our study has shown that kisspeptin can be used as a physiological trigger for egg maturation in IVF therapy," said Professor Dhillo. "It's been a joy to see 12 healthy babies born using this approach. We will now be doing more studies to test whether kisspeptin reduces the risk of OHSS in women who are most prone to developing it, with a view to improving the safety of IVF therapy."

Alison and Richard Harper had a baby boy, Owen, in October 2013 after taking part in the trial in January.

"We took part because we wanted to pay it forward in return for the people who made it possible for us to have a child through IVF," Alison said.

"I went through several cycles of IVF previously but the one in the trial was the least uncomfortable -- it was less painful and I felt less swollen. The staff we dealt with were incredible."


Story Source:

The above story is based on materials provided by Imperial College London. The original article was written by Sam Wong. Note: Materials may be edited for content and length.


Journal Reference:

  1. Channa N. Jayasena, Ali Abbara, Alexander N. Comninos, Gurjinder M.K. Nijher, Georgios Christopoulos, Shakunthala Narayanaswamy, Chioma Izzi-Engbeaya, Mathini Sridharan, Alexina J. Mason, Jane Warwick, Deborah Ashby, Mohammad A. Ghatei, Stephen R. Bloom, Anna Carby, Geoffrey H. Trew, Waljit S. Dhillo. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. Journal of Clinical Investigation, 2014; DOI: 10.1172/JCI75730

Cite This Page:

Imperial College London. "New trigger for ovulation could make IVF safer." ScienceDaily. ScienceDaily, 18 July 2014. <www.sciencedaily.com/releases/2014/07/140718214944.htm>.
Imperial College London. (2014, July 18). New trigger for ovulation could make IVF safer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/07/140718214944.htm
Imperial College London. "New trigger for ovulation could make IVF safer." ScienceDaily. www.sciencedaily.com/releases/2014/07/140718214944.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) — A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) — The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) — After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) — Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins